Literature DB >> 7682540

Patterns of cytokeratin expression by neoplastic and non-neoplastic epithelium.

G Mortimer1, D N Jones, H Assaf, T al-Ahmadi.   

Abstract

Eighty-one epithelial lesions were studied immunohistologically for cytokeratin protein expression using three anticytokeratins CAM 5.2, NCL5D3 and RCK102. Consistent differences were noted between squamous and glandular neoplasms. Squamous and cutaneous carcinomas were found to preferentially express higher molecular weight cytokeratins than adenocarcinomas. In addition, tumours of similar morphology from different sites showed differences in expression of these markers. Differences in pattern were also found between benign and malignant lesions in the case of liver and urinary bladder. Thus the value of cytokeratin profile analysis in characterisation of epithelial neoplasms is confirmed and may be useful in distinguishing benign from malignant tumours in some instances.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682540     DOI: 10.1007/bf02942094

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  26 in total

1.  Anaplastic thyroid carcinoma. A study of 70 cases.

Authors:  M L Carcangiu; T Steeper; G Zampi; J Rosai
Journal:  Am J Clin Pathol       Date:  1985-02       Impact factor: 2.493

Review 2.  Cytokeratin immunocytochemistry in the practice of diagnostic histopathology.

Authors:  G Viale
Journal:  Ultrastruct Pathol       Date:  1988       Impact factor: 1.094

3.  Cytokeratin pattern in normal and pathological bladder urothelium: immunohistochemical investigation using monoclonal antibodies.

Authors:  M Cintorino; M T Del Vecchio; M Bugnoli; R Petracca; P Leoncini
Journal:  J Urol       Date:  1988-02       Impact factor: 7.450

4.  Keratins versus epithelial membrane antigen.

Authors:  A M Gown
Journal:  Hum Pathol       Date:  1988-01       Impact factor: 3.466

5.  NCL-5D3: a new monoclonal antibody recognizing low molecular weight cytokeratins effective for immunohistochemistry using fixed paraffin-embedded tissue.

Authors:  B Angus; J Purvis; D Stock; B R Westley; A C Samson; E G Routledge; F H Carpenter; C H Horne
Journal:  J Pathol       Date:  1987-12       Impact factor: 7.996

6.  Immunohistochemistry of cytokeratin proteins in squamous and transitional cell lesions of the urinary tract.

Authors:  M F Tungekar; K C Gatter; M S Al-Adnani
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

7.  Mucin-negative biopsy in extra-mammary Paget's disease. A diagnostic problem.

Authors:  A Alguacil-Garcia; R O'Connor
Journal:  Histopathology       Date:  1989-10       Impact factor: 5.087

8.  A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins.

Authors:  P Van Eyken; R Sciot; V J Desmet
Journal:  Histopathology       Date:  1989-08       Impact factor: 5.087

9.  Expression of low molecular weight cytokeratin proteins in cervical neoplasia.

Authors:  L G Bobrow; C A Makin; S Law; W F Bodmer
Journal:  J Pathol       Date:  1986-02       Impact factor: 7.996

10.  Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins.

Authors:  E D Jarasch; R B Nagle; M Kaufmann; C Maurer; W J Böcker
Journal:  Hum Pathol       Date:  1988-03       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.